MFDS — authorised 1 July 2009
- Marketing authorisation holder: SANOFI AVENTIS US
- Status: likely_approved
🇰🇷 Multaq in South Korea
MFDS authorised Multaq on 1 July 2009
Marketing authorisation
Multaq in other countries
Same drug, different regulators. Each page below lists the local marketing authorisation, HTA position, pricing, and adverse-event data.
Other Cardiovascular approved in South Korea
Frequently asked questions
Is Multaq approved in South Korea?
Yes. MFDS authorised it on 1 July 2009.
Who is the marketing authorisation holder for Multaq in South Korea?
SANOFI AVENTIS US holds the South Korean marketing authorisation.